Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 16.08%1.4B | 10.56%1.27B | 6.00%4.81B | 7.23%1.23B | 4.87%1.22B | 9.35%1.21B | 2.77%1.15B | 0.56%4.54B | 2.72%1.15B | -2.86%1.16B |
| Net interest income | 1.16%604.4M | 6.73%608.54M | 10.42%2.35B | 12.72%583.17M | 12.47%602.61M | 6.79%597.45M | 9.91%570.17M | -6.29%2.13B | -0.58%517.36M | -9.30%535.78M |
| -Total interest income | -1.79%1.5B | 0.02%1.53B | 1.29%6.15B | 0.46%1.52B | 2.14%1.57B | -0.89%1.53B | 3.55%1.53B | 22.00%6.07B | 6.99%1.52B | 15.40%1.53B |
| -Total interest expense | -3.68%899.95M | -3.97%921.07M | -3.64%3.8B | -5.90%939.22M | -3.41%963.21M | -5.25%934.29M | 0.11%959.16M | 45.82%3.94B | 11.38%998.12M | 35.18%997.17M |
| Non interest income | 30.71%796.36M | 14.33%663.05M | 2.08%2.45B | 2.74%650.36M | -1.66%614.21M | 11.97%609.24M | -3.41%579.95M | 7.51%2.4B | 5.58%632.99M | 3.43%624.57M |
| -Fees and commissions | -11.22%147.93M | -11.64%151.22M | 1.05%658.52M | -7.54%160.74M | -7.40%160.02M | 11.65%166.62M | 9.84%171.13M | 9.85%651.7M | 9.74%173.85M | 6.17%172.81M |
| -Including:Fees and commission income | -11.22%147.93M | -11.64%151.22M | 1.05%658.52M | -7.54%160.74M | -7.40%160.02M | 11.65%166.62M | 9.84%171.13M | 9.85%651.7M | 9.74%173.85M | 6.17%172.81M |
| -Dividend income | 1.41%5.32M | -13.80%8.04M | 53.82%60.4M | -6.11%9.08M | 54.06%36.74M | 146.83%5.25M | 157.72%9.33M | 36.60%39.26M | 84.93%9.67M | 36.60%23.85M |
| -Gain loss on sale of securities | 28.43%537.21M | 90.05%436.15M | -25.36%1.29B | -51.90%341.58M | -32.83%217.96M | 19.16%418.28M | -32.22%229.49M | 28.31%1.72B | 96.70%710.18M | -13.18%324.49M |
| -Net reversal of impairment loss of financial instruments | -3,898.12%-141.63M | -142.91%-12.51M | -55.53%7.2M | 173.82%6.82M | -41.18%2.82M | 385.55%3.73M | -125.55%-5.15M | 35.55%16.2M | -75.26%-9.24M | -67.56%4.79M |
| -Total other operating income | 247.57%77.68M | -73.56%17.57M | -51.64%177.75M | -2.77%53.08M | 73.55%192.73M | -199.60%-52.64M | -54.70%66.45M | 21.58%367.53M | -39.73%54.59M | 322.91%111.05M |
| Credit losses provision | 308.10%168.3M | 365.22%85.7M | -76.01%154.51M | 102.44%59.8M | -91.83%35.05M | 181.14%41.24M | -89.20%18.42M | 88.14%643.95M | -47.37%29.54M | 219.33%429.17M |
| Operating expense | 7.00%565.72M | 8.38%562.93M | 7.18%2.19B | 8.90%575.37M | 9.48%569.69M | 7.59%528.71M | 2.63%519.39M | 2.68%2.05B | -4.66%528.36M | 5.01%520.34M |
| Staff costs | 7.79%378.62M | 11.48%379.8M | 8.75%1.46B | 7.34%380.24M | 14.85%385.23M | 11.67%351.25M | 1.41%340.68M | 1.70%1.34B | -5.85%354.23M | 3.94%335.41M |
| Selling and administrative expenses | 6.31%58.38M | 4.60%57.99M | 4.58%237.84M | 16.35%66.99M | -10.27%60.5M | 9.27%54.91M | 6.26%55.44M | 13.52%227.42M | 3.53%57.58M | 24.23%67.42M |
| -Selling and marketing expense | 7.86%16.09M | 1.21%15.63M | -1.68%71.33M | 15.83%21.68M | -1.64%19.29M | -18.09%14.92M | -3.55%15.45M | 2.85%72.55M | -13.92%18.71M | 16.92%19.61M |
| -General and administrative expense | 5.74%42.29M | 5.91%42.35M | 7.51%166.51M | 16.60%45.31M | -13.80%41.21M | 24.82%40M | 10.60%39.99M | 19.31%154.87M | 14.72%38.86M | 27.50%47.81M |
| Depreciation and amortization | 4.92%39.5M | 9.02%38.93M | -12.12%147.72M | 3.64%36.4M | 1.12%37.98M | -22.68%37.65M | -23.62%35.7M | -17.40%168.1M | -29.86%35.12M | -28.61%37.55M |
| -Depreciation | -4.65%26.87M | -0.98%27.55M | -6.51%109.46M | -8.69%26.17M | -6.57%27.3M | -6.41%28.18M | -4.40%27.82M | -6.21%117.08M | -4.34%28.66M | -7.83%29.22M |
| -Amortization | 33.38%12.63M | 44.31%11.38M | -25.01%38.26M | 58.33%10.23M | 28.09%10.68M | -49.03%9.47M | -55.32%7.89M | -35.16%51.02M | -67.88%6.46M | -60.12%8.34M |
| Insurance and claims | -0.60%2.65M | 0.28%2.47M | -3.32%9.48M | -15.64%1.99M | -0.42%2.37M | -2.24%2.67M | 4.81%2.46M | 4.42%9.81M | 16.20%2.35M | 22.70%2.38M |
| Other operating expenses | 5.27%86.57M | -1.60%83.75M | 13.29%340.73M | 13.51%89.76M | 7.79%83.62M | 9.33%82.24M | 23.56%85.11M | 14.88%300.76M | 12.60%79.08M | 21.20%77.58M |
| Income from associates and other participating interests | 82.19%30.57M | -5.15%30.67M | 169.43%107.85M | 42.79%38.9M | 231.29%19.83M | -7.06%16.78M | 228.70%32.33M | -8.07%40.03M | -21.31%27.24M | -230.53%-15.11M |
| Special income (charges) | 14,109.52%2.98M | -25.91%755K | 109.85%18.89M | 99,305.26%18.89M | 100.00%-2K | -99.15%21K | 265.23%1.02M | -2,093.45%-191.81M | -99.79%19K | -834,634.78%-191.94M |
| Less:Restructuring and mergern&acquisition | ---- | ---- | --0 | --0 | --0 | ---- | ---- | --80M | --0 | --80M |
| Less:Other special charges | ---37K | ---4K | -714.29%-1.08M | -5,610.53%-1.09M | --2K | ---- | ---- | 98.53%-133K | 99.79%-19K | ---- |
| Less:Write off | -13,933.33%-2.95M | 26.30%-751K | -115.90%-17.8M | ---17.8M | --0 | 99.11%-21K | -274.63%-1.02M | 19,568.35%111.94M | --0 | --111.94M |
| Income before tax | 7.15%700.28M | 1.35%654.38M | 52.72%2.59B | 5.88%656.15M | 16,599.60%631.91M | 5.75%653.53M | 42.65%645.65M | -24.00%1.69B | 12.02%619.72M | -99.34%3.78M |
| Income tax | 8.43%165.74M | -4.95%138.32M | 495.11%585.89M | -0.72%142.05M | 126.95%145.46M | 3.26%152.86M | 45.14%145.52M | -128.90%-148.28M | 13.79%143.08M | -509.06%-539.67M |
| Net income | 6.76%534.54M | 3.18%516.06M | 5.70%2B | 7.86%514.11M | -10.49%486.46M | 6.54%500.67M | 23.96%500.13M | 14.76%1.89B | 11.50%476.64M | 22.32%543.45M |
| Net income continuous operations | 6.76%534.54M | 3.18%516.06M | 8.63%2B | 7.86%514.11M | -10.49%486.46M | 6.54%500.67M | 41.94%500.13M | 7.36%1.84B | 11.50%476.64M | 22.32%543.45M |
| Net income discontinuous operations | ---- | ---- | --0 | --0 | --0 | --0 | --0 | 177.36%51.12M | --0 | --0 |
| Noncontrolling interests | -143.43%-43K | -77.61%-119K | -99.29%181K | 81.00%181K | -182.05%-32K | -40.00%99K | -100.27%-67K | 143.16%25.4M | 5.26%100K | -56.18%39K |
| Net income attributable to the company | 6.79%534.58M | 3.19%516.18M | 7.12%2B | 7.85%513.93M | -10.48%486.49M | 6.56%500.57M | 32.20%500.2M | 9.32%1.87B | 11.50%476.54M | 22.33%543.41M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 6.79%534.58M | 3.19%516.18M | 7.12%2B | 7.85%513.93M | -10.48%486.49M | 6.56%500.57M | 32.20%500.2M | 9.32%1.87B | 11.50%476.54M | 22.33%543.41M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 6.74%0.1616 | 3.37%0.1564 | 7.20%0.6056 | 7.91%0.1555 | -10.41%0.1471 | 6.62%0.1514 | 32.26%0.1513 | 9.43%0.5649 | 11.53%0.1441 | 22.35%0.1642 |
| Diluted earnings per share | 6.74%0.1616 | 3.37%0.1564 | 7.20%0.6056 | 7.91%0.1555 | -10.41%0.1471 | 6.62%0.1514 | 32.26%0.1513 | 9.43%0.5649 | 11.53%0.1441 | 22.35%0.1642 |
| Dividend per share | 0 | 19.88%0.199 | 46.99%0.269 | 0 | 71.67%0.103 | 0 | 34.96%0.166 | 66.36%0.183 | 0 | 0.00%0.06 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.